Pexeva

Pexeva is a brand name of paroxetine, approved by the FDA in the following formulation(s):

PEXEVA (paroxetine mesylate - tablet; oral)

• 
  Manufacturer: NOVEN THERAP
  
  Approval date: July 3, 2003
  
  Strength(s): EQ 10MG BASE, EQ 20MG BASE, EQ 30MG BASE, EQ 40MG BASE ^[RLD]

Has a generic version of Pexeva been approved?

No. There is currently no therapeutically equivalent version of Pexeva available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pexeva. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  4-Phenylpiperidine compounds for treating depression
  Patent 5,874,447
  Issued: February 23, 1999
  Inventor(s): Benneker; Franciscus Bernardus Gemma & Van Dalen; Frans & Lemmens; Jacobus Maria & Peters; Theodorus Hendricus Antonium & Picha; Frantisek
  Assignee(s): Synthon B. V.
  The invention relates to a compound, and pharmaceutically acceptable salts, having the formula I: ##STR1## wherein: R represents an alkyl or alkynyl group having 1-4 carbon atoms, or a phenyl group optionally substituted by C.sub.1-4 alkyl, alkylthio, alkoxy, halogen, nitro, acylamino, methylsulfonyl or methylenedioxy, or represents tetrahydronaphthyl, R.sup.1 represents hydrogen, trifluoro (C.sub.1-4) alkyl, alkyl or alkynyl, X represents hydrogen, alkyl having 1-4 carbon atoms, alkoxy, trifluoroalkyl, hydroxy, halogen, methylthio or aralkoxy, R.sup.2 represents: a C1-C10 alkyl group, a phenyl group optionally substituted by one or more of the following groups: a C1-C10 alkyl group, a halogen group, a nitro group, hydroxy group, and/or an alkoxy group.
  
  Patent expiration dates:
  
  
  • June 10, 2017
    
    ✓ 
    Patent use: OBSESSIVE COMPULSIVE DISORDER
  
  
  
  • June 10, 2017
    
    ✓ 
    Patent use: TREATMENT OF PANIC DISORDER
  
  
  
  • June 10, 2017
    
    ✓ 
    Patent use: DEPRESSION
  
  



• 
  N-formyl derivatives of paroxetine
  Patent 6,703,408
  Issued: March 9, 2004
  Inventor(s): Hans J.; Hoorn & Theodorus H. A.; Peters & Frantisek; Picha
  Assignee(s): Synthon BCT Technologies, LLC
  A compound or composition comprising N-formyl paroxetine of formula (1) is useful as a pharmaceutical and as a synthetic intermediate. The N-formyl paroxetine can be an impurity in paroxetine substances and methods of assaying for such an impurity are also useful.
  
  Patent expiration dates:
  
  
  • October 21, 2022
    
    ✓ 
    Drug product
  
  



• 
  Crystalline paroxetine methane sulfonate
  Patent 7,598,271
  Issued: October 6, 2009
  Inventor(s): Benneker; Franciscus Bernardus Gemma & Van Dalen; Frans & Lemmens; Jacobus Maria & Peters; Theodorus Hendricus Antonium & Picha; Frantisek
  Assignee(s): Noven Therapeutics, LLC
  The invention relates to a compound, and pharmaceutically acceptable salts, having the formula I: wherein: R represents an alkyl or alkynyl group having 1-4 carbon atoms, or a phenyl group optionally substituted by C1-4 alkyl, alkylthio, alkoxy, halogen, nitro, acylamino, methylsulfonyl or methylenedioxy, or represents tetrahydronaphthyl, R1 represents hydrogen, trifluoro (C1-4) alkyl, alkyl or alkynyl, X represents hydrogen, alkyl having 1-4 carbon atoms, alkoxy, trifluoroalkyl, hydroxy, halogen, methylthio or aralkoxy, R2 represents: a C1-C10 alkyl group, a phenyl group optionally substituted by one or more of the following groups: a C1-C10 alkyl group, a halogen group, a nitro group, hydroxy group, and/or an alkoxy group.
  
  Patent expiration dates:
  
  
  • February 11, 2023
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Pexeva Consumer Information (Wolters Kluwer)
• Pexeva Consumer Information (Cerner Multum)
• Pexeva Advanced Consumer Information (Micromedex)
• Paroxetine Consumer Information (Drugs.com)
• Paroxetine Consumer Information (Wolters Kluwer)
• Paroxetine Controlled-Release Tablets Consumer Information (Wolters Kluwer)
• Paroxetine Mesylate Consumer Information (Wolters Kluwer)
• Paroxetine Suspension Consumer Information (Wolters Kluwer)
• Paroxetine Consumer Information (Cerner Multum)
• Paroxetine Advanced Consumer Information (Micromedex)
• Paroxetine Hydrochloride AHFS DI Monographs (ASHP)